Community Pharmacy England (CPE) - News updates

More than half of pharmacy owners are yet to complete their Data Security and Protection Toolkit 2025 ahead of the imminent deadline in less than two weeks. Community Pharmacy England has published guidance to help community pharmacy owners complete the Data Security and Protection Toolkit 2025. The Toolkit is used to make a pharmacy’s information [...] The post Approaching deadline: Nearly 50% of pharmacies still to submit Data Security Toolkit appeared first on Community Pharmacy England.

The Cybersecurity Unit at the Department of Health and Social Care (DHSC) is launching a pilot study to explore the benefits of enhanced cybersecurity support for community pharmacies. This initiative follows a recent sector-wide cyber survey, which highlighted the need for greater support. The pilot is being delivered in collaboration with the National Cyber Security [...] The post Volunteer: Join the pharmacy cybersecurity support pilot appeared first on Community Pharmacy England.

The Royal Osteoporosis Society (ROS) has launched a new BoneMed online service, a free service to supports patients taking medicines for osteoporosis and remove barriers to medicines adherence. After a five minute online survey, patients receive an online medicine summary and six emails over a year tailored to the medicine they’ve been prescribed. Topics covered include: [...] The post New resource for patients with osteoporosis appeared first on Community Pharmacy England.

Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering [...] The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

Following on from last week’s Spending Review announcement, Community Pharmacy England has joined forces with other national primary care bodies to reiterate our call on Government to prioritise DHSC spending allocations towards primary care. The joint statement, copied below, has been signed by Community Pharmacy England, the General Practitioner’s Committee England, the British Dental Association’s [...] The post Joint Primary Care Statement on the Spending Review appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens Levemir® Penfill® 100units/ml solution for injection 3ml cartridges MSN/2025/036 Tier 2 – medium impact Date of issue: 16/06/2025 Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection [...] The post Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges appeared first on Community Pharmacy England.

Several months ago Community Pharmacy England and Healthwatch England launched an online Pharmacy First patient survey that pharmacy owners can direct patients to after receiving the service. The aim of this collaboration is to collect patient feedback on the service to help inform service improvements and to help to quantify the value of the service [...] The post Reminder: please ask your patients to give feedback on Pharmacy First appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...] The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across Yorkshire and the Humber and the North East are invited to ‘Future of [...] The post Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...] The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.